Christopher Mason - Net Worth and Insider Trading

Christopher Mason Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher Mason owns 2 companies in total, including Avrobio Inc (AVRO) , and Krystal Biotech Inc (KRYS) .

Click here to see the complete history of Christopher Mason’s form 4 insider trades.

Insider Ownership Summary of Christopher Mason

Ticker	Comapny	Transaction Date	Type of Owner
AVRO	Avrobio Inc	2021-03-03	Chief Scientific Officer
KRYS	Krystal Biotech Inc	2021-01-04	director

Christopher Mason Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Christopher Mason Ownership Network

Ownership Network List of Christopher Mason

No Data

Ownership Network Relation of Christopher Mason

Christopher Mason Owned Company Details

What does Avrobio Inc do?

Who are the key executives at Avrobio Inc?

Christopher Mason is the Chief Scientific Officer of Avrobio Inc. Other key executives at Avrobio Inc include Chief Technology Officer Azadeh Golipour , Chief Medical Officer Essra Ridha , and Chief Medical Officer Diana Escolar .

Avrobio Inc (AVRO) Insider Trades Summary

Over the past 18 months, Christopher Mason made no insider transaction in Avrobio Inc (AVRO). Other recent insider transactions involving Avrobio Inc (AVRO) include a net purchase of 766,635 shares made by Braden Michael Leonard ,

In summary, during the past 3 months, insiders sold 0 shares of Avrobio Inc (AVRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Avrobio Inc (AVRO) were sold and 63,886 shares were bought by its insiders, resulting in a net purchase of 63,886 shares.

Avrobio Inc (AVRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Avrobio Inc Insider Transactions

No Available Data

Christopher Mason Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher Mason. You might contact Christopher Mason via mailing address: C/o Krystal Biotech, Inc., 2100 Wharton Street, Suite 701, Pittsburgh Pa 15203.

Discussions on Christopher Mason

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.